Inovatyvios dermatologijos centras, UAB - financials and debts
Company age: 16 y. 3 mo.
Inovatyvios dermatologijos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 513,182 | 681,553 | 820,820 | 1,511,639 | 1,949,130 | 2,185,611 | 2,415,781 | 2,815,824 |
| Profit before tax | 39,384 | 42,334 | 177,093 | 415,189 | 342,927 | -302,223 | -4,454 | 24,757 |
| Net profit | 37,360 | 42,334 | 160,374 | 396,163 | 342,927 | -302,223 | -4,454 | 24,757 |
| Equity | 14,094 | 56,429 | 216,803 | 612,966 | 955,893 | 653,668 | 649,214 | 673,971 |
| Liabilities | - | - | - | - | 2,563,254 | 4,456,384 | 4,230,405 | 4,004,284 |
| Non-current assets | 199,704 | 233,793 | 164,478 | 1,676,247 | 3,364,335 | 4,937,435 | 4,694,832 | 4,505,347 |
| Current assets | 14,331 | 13,548 | 178,189 | 95,097 | 154,812 | 172,617 | 184,787 | 172,908 |
| Total assets | 214,035 | 247,341 | 342,667 | 1,771,344 | 3,519,147 | 5,110,052 | 4,879,619 | 4,678,255 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 269,049 | 358,462 |
| Social insurance contributions | - | - | - | - | - | 212,270 | 240,540 | 271,380 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +66.1% | +32.8% | +20.4% | +84.2% | +28.9% | +12.1% | +10.5% | +16.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.5% | 17.1% | 46.8% | 22.4% | 9.7% | -5.9% | -0.1% | 0.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 265.1% | 75.0% | 74.0% | 64.6% | 35.9% | -46.2% | -0.7% | 3.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.3% | 6.2% | 19.5% | 26.2% | 17.6% | -13.8% | -0.2% | 0.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.7% | 6.2% | 21.6% | 27.5% | 17.6% | -13.8% | -0.2% | 0.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 2.7 | 6.8 | 6.5 | 5.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 42,470 | 47,275 | 43,583 | 70,858 | 79,556 | 59,472 | 65,145 | 68,818 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Inovatyvios dermatologijos centras - Social security debts
The amount of overdue SODRA debt for the company Inovatyvios dermatologijos centras as of the last working day is: 60 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-11 | 2026-09-15 | 59.92 |
| 2026-08-23 | 2026-08-23 | 4953.13 |
| 2026-08-19 | 2026-08-19 | 21953.13 |
| 2026-07-19 | 2026-07-20 | 8056.64 |
| 2026-07-16 | 2026-07-17 | 23610.64 |
| 2026-06-18 | 2026-06-21 | 7051.42 |
| 2026-06-17 | 2026-06-17 | 13051.42 |
| 2026-06-16 | 2026-06-16 | 20051.42 |
| 2026-06-11 | 2026-06-14 | 32.21 |
| 2026-05-22 | 2026-06-08 | 32.21 |
| 2026-05-18 | 2026-05-19 | 16523.93 |
| 2026-05-17 | 2026-05-17 | 18523.93 |
| 2026-03-27 | 2026-03-27 | 8878.85 |
| 2026-03-17 | 2026-03-18 | 8878.85 |
| 2026-02-24 | 2026-02-26 | 4584.99 |
| 2026-02-22 | 2026-02-23 | 7584.99 |
| 2026-02-20 | 2026-02-21 | 17584.99 |
| 2026-02-19 | 2026-02-19 | 21982.99 |
| 2026-02-18 | 2026-02-18 | 23544.99 |
| 2026-01-21 | 2026-01-21 | 3376.92 |
| 2026-01-20 | 2026-01-20 | 7666.92 |
| 2026-01-16 | 2026-01-19 | 17666.92 |
| 2025-12-18 | 2025-12-21 | 10503.30 |
| 2025-12-17 | 2025-12-17 | 14503.30 |
| 2025-12-16 | 2025-12-16 | 21564.30 |
| 2025-11-20 | 2025-11-20 | 8893.06 |
| 2025-11-19 | 2025-11-19 | 16005.06 |
| 2025-11-18 | 2025-11-18 | 21545.06 |
| 2025-10-20 | 2025-10-20 | 9127.42 |
| 2025-10-19 | 2025-10-19 | 10127.42 |
| 2025-10-17 | 2025-10-18 | 19527.42 |
| 2025-10-16 | 2025-10-16 | 20471.42 |
| 2025-09-19 | 2025-09-21 | 9546.36 |
| 2025-09-18 | 2025-09-18 | 13646.36 |
| 2025-09-17 | 2025-09-17 | 17546.36 |
| 2025-09-16 | 2025-09-16 | 20646.36 |
| 2025-08-28 | 2025-08-29 | 21089.88 |
| 2025-08-21 | 2025-08-21 | 7650.88 |
| 2025-08-19 | 2025-08-20 | 21089.88 |
| 2025-07-17 | 2025-07-20 | 12483.98 |
| 2025-07-16 | 2025-07-16 | 18040.34 |
| 2025-06-17 | 2025-06-17 | 14787.74 |
| 2025-05-16 | 2025-05-18 | 12610.42 |
| 2025-04-17 | 2025-04-21 | 7751.92 |
| 2025-04-16 | 2025-04-16 | 12751.92 |
| 2025-03-18 | 2025-03-18 | 17947.99 |
| 2025-02-19 | 2025-02-19 | 1994.06 |
| 2025-02-18 | 2025-02-18 | 14470.06 |
| 2025-01-22 | 2025-01-22 | 6750.64 |
| 2025-01-21 | 2025-01-21 | 10050.64 |
| 2025-01-19 | 2025-01-20 | 12550.64 |
| 2025-01-18 | 2025-01-18 | 13304.64 |
| 2025-01-16 | 2025-01-17 | 15704.64 |
| 2024-12-22 | 2024-12-22 | 1390.47 |
| 2024-12-18 | 2024-12-20 | 12390.47 |
| 2024-12-17 | 2024-12-17 | 16140.47 |
| 2024-11-28 | 2024-11-28 | 1916.95 |
| 2024-11-26 | 2024-11-27 | 6566.95 |
| 2024-11-25 | 2024-11-25 | 7316.95 |
| 2024-11-22 | 2024-11-24 | 12666.95 |
| 2024-11-21 | 2024-11-21 | 16466.95 |
| 2024-11-20 | 2024-11-20 | 16925.95 |
| 2024-11-19 | 2024-11-19 | 17134.95 |
| 2024-11-18 | 2024-11-18 | 17616.95 |
| 2024-10-18 | 2024-10-20 | 2511.67 |
| 2024-10-17 | 2024-10-17 | 8511.67 |
| 2024-10-16 | 2024-10-16 | 14111.67 |
| 2024-09-20 | 2024-09-22 | 274.84 |
| 2024-09-19 | 2024-09-19 | 5674.84 |
| 2024-09-18 | 2024-09-18 | 13174.84 |
| 2024-09-17 | 2024-09-17 | 20906.84 |
| 2024-08-23 | 2024-08-25 | 3439.69 |
| 2024-08-22 | 2024-08-22 | 8922.69 |
| 2024-08-21 | 2024-08-21 | 12439.69 |
| 2024-08-20 | 2024-08-20 | 17569.69 |
| 2024-08-19 | 2024-08-19 | 18919.69 |
| 2024-07-16 | 2024-07-30 | 18954.59 |
| 2023-04-18 | 2023-04-23 | 63.74 |
| 2022-09-16 | 2022-10-13 | 2.71 |
| 2022-08-23 | 2022-09-14 | 2.71 |
| 2022-05-17 | 2022-05-26 | 136.54 |
| 2022-04-19 | 2022-05-10 | 109.97 |
| 2022-03-16 | 2022-04-12 | 88.35 |
| 2022-02-17 | 2022-02-27 | 56.60 |
| 2021-11-16 | 2021-11-23 | 10.09 |
Inovatyvios dermatologijos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-18 | 2026-08-19 | 3949.54 |
| 2026-02-21 | 2026-02-21 | 15315.49 |
| 2026-02-18 | 2026-02-20 | 15955.51 |
| 2025-11-18 | 2025-11-18 | 4492.38 |
| 2025-10-16 | 2025-10-18 | 8943.65 |
| 2025-09-17 | 2025-09-17 | 15102.54 |
| 2025-08-19 | 2025-08-19 | 7950.85 |
| 2025-07-27 | 2025-07-27 | 827.45 |
| 2025-07-26 | 2025-07-26 | 4756.02 |
| 2025-07-24 | 2025-07-25 | 4770.23 |
| 2025-07-23 | 2025-07-23 | 7192.79 |
| 2025-07-22 | 2025-07-22 | 12980.19 |
| 2025-07-16 | 2025-07-20 | 5544.68 |
| 2024-12-17 | 2024-12-17 | 7745.24 |
| 2024-11-28 | 2024-11-28 | 2973.39 |
| 2024-11-27 | 2024-11-27 | 1792.49 |
| 2024-11-22 | 2024-11-26 | 1790.24 |
| 2024-11-20 | 2024-11-21 | 8341.04 |
| 2024-11-18 | 2024-11-19 | 12603.04 |
| 2024-11-17 | 2024-11-17 | 12413.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Inovatyvios dermatologijos centras, UAB (company code 302519484) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €2.82M, up 16.6% year on year and 28.8% over two years. Profitability improved materially: after a net loss of €302.2K in 2023 and a near-breakeven loss of €4.5K in 2024, the company reported a net profit of €24.8K in 2025, with a profit margin of 0.9%. The balance sheet remained stable, with total assets of €4.68M, equity of €674.0K and liabilities of €4.00M. Long-term assets accounted for most of the asset base at €4.51M, while short-term assets were €172.9K. Key ratios for 2025 show moderate efficiency and limited leverage support, with ROE at 3.7%, ROA at 0.5%, debt-to-equity at 5.94 and asset turnover at 0.60x. Revenue per employee was €70.4K and profit per employee €619, indicating modest operating profitability in the latest year.